209 related articles for article (PubMed ID: 20138985)
1. Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1.
Nascimento EB; Snel M; Guigas B; van der Zon GC; Kriek J; Maassen JA; Jazet IM; Diamant M; Ouwens DM
Cell Signal; 2010 Jun; 22(6):961-7. PubMed ID: 20138985
[TBL] [Abstract][Full Text] [Related]
2. Insulin-mediated phosphorylation of the proline-rich Akt substrate PRAS40 is impaired in insulin target tissues of high-fat diet-fed rats.
Nascimento EB; Fodor M; van der Zon GC; Jazet IM; Meinders AE; Voshol PJ; Vlasblom R; Baan B; Eckel J; Maassen JA; Diamant M; Ouwens DM
Diabetes; 2006 Dec; 55(12):3221-8. PubMed ID: 17130464
[TBL] [Abstract][Full Text] [Related]
3. PRAS40: target or modulator of mTORC1 signalling and insulin action?
Nascimento EB; Ouwens DM
Arch Physiol Biochem; 2009 Oct; 115(4):163-75. PubMed ID: 19480563
[TBL] [Abstract][Full Text] [Related]
4. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40.
Vander Haar E; Lee SI; Bandhakavi S; Griffin TJ; Kim DH
Nat Cell Biol; 2007 Mar; 9(3):316-23. PubMed ID: 17277771
[TBL] [Abstract][Full Text] [Related]
5. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis.
Mi W; Ye Q; Liu S; She QB
Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of PRAS40 enhances insulin sensitivity in skeletal muscle.
Wiza C; Chadt A; Blumensatt M; Kanzleiter T; Herzfeld De Wiza D; Horrighs A; Mueller H; Nascimento EB; Schürmann A; Al-Hasani H; Ouwens DM
Arch Physiol Biochem; 2014 May; 120(2):64-72. PubMed ID: 24576065
[TBL] [Abstract][Full Text] [Related]
7. Role of PRAS40 in Akt and mTOR signaling in health and disease.
Wiza C; Nascimento EB; Ouwens DM
Am J Physiol Endocrinol Metab; 2012 Jun; 302(12):E1453-60. PubMed ID: 22354785
[TBL] [Abstract][Full Text] [Related]
8. [Preparation and detection of phosphorylated PRAS40 (Ser183) polyclonal antibody].
Wei H; Huang B; Xu C; Zheng Z; Bai Y
Sheng Wu Gong Cheng Xue Bao; 2009 Jul; 25(7):1049-54. PubMed ID: 19835147
[TBL] [Abstract][Full Text] [Related]
9. Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway.
Wang H; Zhang Q; Wen Q; Zheng Y; Lazarovici P; Jiang H; Lin J; Zheng W
Cell Signal; 2012 Jan; 24(1):17-24. PubMed ID: 21906675
[TBL] [Abstract][Full Text] [Related]
10. IGF-1 stimulates protein synthesis by enhanced signaling through mTORC1 in bovine mammary epithelial cells.
Burgos SA; Cant JP
Domest Anim Endocrinol; 2010 May; 38(4):211-21. PubMed ID: 20163929
[TBL] [Abstract][Full Text] [Related]
11. Regulation of proline-rich Akt substrate of 40 kDa (PRAS40) function by mammalian target of rapamycin complex 1 (mTORC1)-mediated phosphorylation.
Wang L; Harris TE; Lawrence JC
J Biol Chem; 2008 Jun; 283(23):15619-27. PubMed ID: 18372248
[TBL] [Abstract][Full Text] [Related]
12. The binding of PRAS40 to 14-3-3 proteins is not required for activation of mTORC1 signalling by phorbol esters/ERK.
Fonseca BD; Lee VH; Proud CG
Biochem J; 2008 Apr; 411(1):141-9. PubMed ID: 18215133
[TBL] [Abstract][Full Text] [Related]
13. Proline-rich Akt substrate of 40-kDa contains a nuclear export signal.
Wiza C; Nascimento EB; Linssen MM; Carlotti F; Herzfeld de Wiza D; van der Zon GC; Maassen JA; Diamant M; Guigas B; Ouwens DM
Cell Signal; 2013 Sep; 25(9):1762-8. PubMed ID: 23712034
[TBL] [Abstract][Full Text] [Related]
14. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
15. Effect of conditioned media from mature human adipocytes on insulin-stimulated Akt/PKB phosphorylation in human skeletal muscle cells: role of BMI and fat cell size.
Skurk T; Alberti-Huber C; Hauner H
Horm Metab Res; 2009 Mar; 41(3):190-6. PubMed ID: 18956303
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of PRAS40 inhibits insulin action via proteasome-mediated degradation of IRS1 in primary human skeletal muscle cells.
Wiza C; Herzfeld de Wiza D; Nascimento EB; Lehr S; Al-Hasani H; Ouwens DM
Diabetologia; 2013 May; 56(5):1118-28. PubMed ID: 23460019
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of insulin-stimulated 4E-BP protein binding to mammalian target of rapamycin (mTOR) complex 1 and its contribution to mTOR complex 1 signaling.
Rapley J; Oshiro N; Ortiz-Vega S; Avruch J
J Biol Chem; 2011 Nov; 286(44):38043-38053. PubMed ID: 21914810
[TBL] [Abstract][Full Text] [Related]
18. The proline-rich Akt substrate of 40 kDa (PRAS40) is a physiological substrate of mammalian target of rapamycin complex 1.
Oshiro N; Takahashi R; Yoshino K; Tanimura K; Nakashima A; Eguchi S; Miyamoto T; Hara K; Takehana K; Avruch J; Kikkawa U; Yonezawa K
J Biol Chem; 2007 Jul; 282(28):20329-39. PubMed ID: 17517883
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-1 induces the phosphorylation of PRAS40 via the PI3K/Akt signaling pathway in PC12 cells.
Wang H; Zhang Q; Zhang L; Little PJ; Xie X; Meng Q; Ren Y; Zhou L; Gao G; Quirion R; Zheng W
Neurosci Lett; 2012 May; 516(1):105-9. PubMed ID: 22490886
[TBL] [Abstract][Full Text] [Related]
20. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase.
Sancak Y; Thoreen CC; Peterson TR; Lindquist RA; Kang SA; Spooner E; Carr SA; Sabatini DM
Mol Cell; 2007 Mar; 25(6):903-15. PubMed ID: 17386266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
